The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Molecular Mechanisms of Primary Resistance to Flucytosine in Candida albicans
Open accessAbstract
Primary resistance in Candida albicans to flucytosine (5-FC) was investigated in 25 strains by identifying and sequencing the genes FCA1, FUR1, FCY21, and FCY22, which code for cytosine deaminase, uracil phosphoribosyltransferase (UPRT), and two purine-cytosine permeases, respectively. These proteins are involved in pyrimidine salvage and 5-FC metabolism. An association between a polymorphic nucleotide and resistance to 5-FC was found within FUR1 where the substitution of cytidylate for thymidylate at nucleotide position 301 results in the replacement of arginine with cysteine at amino acid position 101 in UPRT. Isolates that are homozygous for this mutation display increased levels of resistance to 5-FC, whereas heterozygous isolates have reduced susceptibility. Three-dimensional protein modeling of UPRT suggests that the Arg101Cys mutation disturbs the quaternary structure of the enzyme, which is postulated to compromise optimal enzyme activity. A single resistant isolate, lacking the above polymorphism in FUR1, has a homozygous polymorphism in FCA1 that results in a glycine-to-aspartate substitution at position 28 in cytosine deaminase.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Decreased susceptibility towards flucytosine has been associated with point mutations in FCY1, FCY2, and FUR1 genes and the deletion of FPS1 and FPS2 genes [36,114,115,116,117].”
From Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens (2018) · cites this paper as [114]
In the citing paper
“Such resistance mechanisms have been observed in C. albicans [114], C. lusitaniae [115], and C. glabrata [116,117].”
From Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens (2018) · cites this paper as [114]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tree View: An application to display phylogenetic trees on personal computers
Page, R. (1996) · Computer applications in the biosciences · doi:10.1093/bioinformatics/12.4.357 · Cited by 10,223
The Neutral Theory of Molecular Evolution
Kimura, M. (1979) · Scientific American · doi:10.1038/scientificamerican1179-98 · Cited by 7,687
The Neutral Theory of Molecular Evolution
Kimura, M. (1983) · Cambridge University Press eBooks · doi:10.1017/cbo9780511623486 · Cited by 6,300
Amino acid substitution matrices from protein blocks.
Henikoff, S., & Henikoff, J. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10915 · Cited by 6,218
THE JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
(1975) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1975.tb105896.x · Cited by 1,902
Vermes, A. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.2.171 · Cited by 803
Amino acid substitution matrices
Henikoff, S., & Henikoff, J. G. (2000) · Advances in protein chemistry · doi:10.1016/s0065-3233(00)54003-0 · Cited by 441
Mode of action of 5-fluorocytosine and mechanisms of resistance
Polak, A., & Scholer, H. J. (2009) · Chemotherapy · doi:10.1159/000221854 · Cited by 250 · cited 1×
“The prospect of more than one resistance mechanism is also supported by the early observation that there was a large degree of variability in the incorporation of fluorinated pyrimidine nucleotides into RNA for a group of isolates with otherwise similar levels of susceptibility to 5-FC (17).”
BackgroundRodríguez-Tudela, J. L., Barchiesi, F., Billé, J., Chryssanthou, E., Cuenca‐Estrella, M., Denning, D. W., Donnelly, J. P., Dupont, B., Fegeler, W., Moore, C. B., et al. (2003) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2003.00789.x · Cited by 208
Self-citationGenetic and Physiological Aspects of Resistance to 5-Fluoropyrimidines in Saccharomyces cerevisiae
Jund, R., & Lacroute, F. (1970) · Journal of Bacteriology · doi:10.1128/jb.102.3.607-615.1970 · Cited by 191
Mechanisms of action of 5-fluorocytosine
Waldorf, A. R., & Polak, A. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.23.1.79 · Cited by 141
Dodgson, A. R., Dodgson, K. J., Pujol, C., Pfaller, M. A., & Soll, D. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2223-2227.2004 · Cited by 133
Pfaller, M. A., Messer, S. A., Boyken, L., Huynh, H., Hollis, R. J., & Diekema, D. J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3518-3521.2002 · Cited by 132
In Vitro Studies of 5-Fluorocytosine Resistance in Candida albicans and Torulopsis glabrata
Normark, S. J., & Schönebeck, J. (1972) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.2.3.114 · Cited by 100
Vancomycin use--an historical review
Griffith, R. S. (1984) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/14.suppl_d.1 · Cited by 90
Tpn1p, the Plasma Membrane Vitamin B6 Transporter of Saccharomyces cerevisiae
Stolz, J., & Vielreicher, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300949200 · Cited by 87
Flucytosine Resistance Is Restricted to a Single Genetic Clade of Candida albicans
Pujol, C., Pfaller, M. A., & Soll, D. R. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.262-266.2004 · Cited by 81
Kern, L., de Montigny, J., Jund, R., & Lacroute, F. (1990) · Gene · doi:10.1016/0378-1119(90)90026-n · Cited by 79
Weber, E., Rodriguez, C., Chevallier, M. R., & Jund, R. (1990) · Molecular Microbiology · doi:10.1111/j.1365-2958.1990.tb00627.x · Cited by 78
Schumacher, M. A., Carter, D., Scott, D. M., Roos, D. S., Ullman, B., & Brennan, R. G. (1998) · The EMBO Journal · doi:10.1093/emboj/17.12.3219 · Cited by 74
Erbs, P., Exinger, F., & Jund, R. (1997) · Current Genetics · doi:10.1007/s002940050169 · Cited by 60
Whelan, W. L., & Kerridge, D. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.26.4.570 · Cited by 53
Primary resistance to flucytosine among clinical isolates of Candida spp.
Barchiesi, F., Arzeni, D., Caselli, F., & Scalise, G. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.3.408 · Cited by 53
Natalini, P., Ruggieri, S., Santarelli, I. F., Vita, A., & Magni, G. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37808-0 · Cited by 44
The GeneMine system for genome/proteome annotation and collaborative data mining
Lee, C., & Irizarry, K. J. L. (2001) · IBM Systems Journal · doi:10.1147/sj.402.0592 · Cited by 39
Schumacher, M. A., Bashor, C. J., Song, M. H., Otsu, K., Zhu, S., Parry, R. J., Ullman, B., & Brennan, R. G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012399599 · Cited by 38
Laboratory methods for flucytosine (5-fluorocytosine)
Speller, D. C. E., Cartwright, R. Y., Evans, E. G. V., Hay, R. J., Mackenzie, D. W. R., Milne, L. J. R., Odds, F. C., Warnock, D. W., & Wingfield, H. J. (1984) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/14.1.1 · Cited by 33
Schmidt, R., Manolson, M. F., & Chevallier, M. R. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.20.6276 · Cited by 31
Polak, A., & Wain, W. H. (2009) · Chemotherapy · doi:10.1159/000221992 · Cited by 25
Isolation and Characterization of Fluoropyrimidine‐Resistant Mutants in Two Candida Species
FASOLI, M., & Kerridge, D. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb40411.x · Cited by 23
Jensen, H. K., Mikkelsen, N., & Neuhard, J. (1997) · Protein Expression and Purification · doi:10.1006/prep.1997.0755 · Cited by 20
Regulation of the pyrimidine salvage pathway by the FUR1 gene product of Saccharomyces cerevisiae
Kern, L., de Montigny, J., Lacroute, F., & Jund, R. (1991) · Current Genetics · doi:10.1007/bf00309592 · Cited by 20
Cited by
Sorted by citations
Mechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647
Antifungal Resistance and New Strategies to Control Fungal Infections
Vandeputte, P., Ferrari, S., & Coste, A. T. (2011) · International Journal of Microbiology · doi:10.1155/2012/713687 · Cited by 531
Pfaller, M. A., & Diekema, D. J. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00937-12 · Cited by 484
Candidiasis and Mechanisms of Antifungal Resistance
Bhattacharya, S., Sae-Tia, S., & Fries, B. C. (2020) · Antibiotics · doi:10.3390/antibiotics9060312 · Cited by 474
Mechanisms of Candida Biofilm Drug Resistance
Taff, H. T., Mitchell, K. F., Edward, J. A., & Andes, D. R. (2013) · Future Microbiology · doi:10.2217/fmb.13.101 · Cited by 422
Metadata
- Authors
- Hope, W. W., Tabernero, L., Denning, D. W., & Anderson, M. J.
- Affiliations
- National Institutes of Health (US)
- University of Manchester (GB)
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2004-11
- Volume
- 48
- Issue
- 11
- Pages
- 4377-4386
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC525410
- OpenAlex
- W2124393272
- Cited by
- 160
- References
- 33
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 9 · 2023: 13 · 2022: 6 · 2021: 13 · 2020: 10 · 2019: 5 · 2018: 5 · 2017: 13 · 2016: 7 · 2015: 7 · 2014: 6 · 2013: 5 · 2012: 8
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- flucytosine resistance, Candida albicans, uracil phosphoribosyltransferase, cytosine deaminase, pyrimidine salvage pathway, single nucleotide polymorphisms, quaternary structure, antifungal resistance
- MeSH terms
- Amino Acid Sequence, Antifungal Agents, Antimetabolites, Candida albicans, DNA, Fungal, Flucytosine, Fluorouracil, Genes, Fungal, Microbial Sensitivity Tests, Models, Molecular, Molecular Sequence Data, Pentosyltransferases, Polymorphism, Genetic, DNA Primers, Reverse Transcriptase Polymerase Chain Reaction, Drug Resistance, Fungal, Membrane Transport Proteins, Saccharomyces cerevisiae Proteins, Nucleobase Transport Proteins, Cytosine Deaminase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
